BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-049 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-049@nextconsensus.com
DTSTAMP:20261015T000000Z
DTSTART;VALUE=DATE:20270210
DTEND;VALUE=DATE:20270211
SUMMARY:FF-049 deadline: Pembrolizumab · muscle-invasive bladder cancer gu
 idance publication
DESCRIPTION:Registered forecast FF-049 (NICE)\, Pembrolizumab · muscle-inv
 asive bladder cancer guidance publication. It asks whether this happens by
  2027-02-10. The record: https://nextconsensus.com/forecast/ff-049/
URL:https://nextconsensus.com/forecast/ff-049/
CATEGORIES:Registered forecast,NICE
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR